MFN2 and metabolic dysfunction-associated steatohepatitis: The significant reduction in the expression of mitofusin 2 (MFN2) and translocase of the outer membrane 20 (TOM20) in the livers of patients with NASH also suggested that the number of mitochondria was lower, and they had defects in fusion.